Skip to content

ENTX - Entera Bio Ltd. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchE

Entera Bio Ltd

ENTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

E

ENTXEntera Bio Ltd

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $4.20
52-wk low: $0.91
Prev close: $2.96
Mkt cap: $538.5M
Beta: 1.40
P/S: 1547.1x

Smart money

4 funds hold a position.

Real smart money

Funds holding this stock

4 holders

Combined position$893K

JS
Jim Simons
Q2 2026 13F
$653K
position
SC
Schonfeld
Steven Schonfeld · Q2 2026 13F

Earnings

Reported Aug 7, 2026

Earnings came in $0.06 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $538M

Valuation

P/S1547.08
P/B69.10

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ENTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $538.47M
Beta: 1.40

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

69.1x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-138.9%

$104K

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$69K

position

1 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 1 holders

Coverage gaps for ENTX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.14-$0.06

-$0.08 expected

Next report

What the street expects next

EPS expected

-$0.08

-$0.08 to -$0.08

Revenue expected

$0.00

1 analysts

Last 30 days

1up0down

Analysts raising estimates

-138.9%

ROA-46.0%

Growth

Beta1.40